Cargando…
Research progress of m(6)A methylation in prostate cancer
N(6)-methyladenosine (m(6)A) is a ubiquitous RNA modification in mammals. This modification is “written” by methyltransferases and then “read” by m(6)A-binding proteins, followed by a series of regulation, such as alternative splicing, translation, RNA stability, and RNA translocation. At last, the...
Autores principales: | Zhang, Shou-Yi, Zeng, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069701/ https://www.ncbi.nlm.nih.gov/pubmed/36308073 http://dx.doi.org/10.4103/aja202265 |
Ejemplares similares
-
Research progress concerning m(6)A methylation and cancer
por: Zhou, Yang, et al.
Publicado: (2021) -
PI3K-AKT-mTOR signaling in prostate cancer progression and androgen deprivation therapy resistance
por: Edlind, Merritt P, et al.
Publicado: (2014) -
The role of mRNA splicing in prostate cancer
por: Lapuk, Anna V, et al.
Publicado: (2014) -
Beta-adrenergic signaling on neuroendocrine differentiation, angiogenesis, and metastasis in prostate cancer progression
por: Zhao, Yicheng, et al.
Publicado: (2019) -
The regulatory pathways leading to stem-like cells underlie prostate cancer progression
por: Lin, Chun-Jung, et al.
Publicado: (2019)